View in EDS HTML Full Text PDF Full Text

Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.

Saved in:
Bibliographic Details
Title: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.
Authors: Kraft CS; Department of Pathology and Laboratory Medicine, Division of Infectious Diseases, Emory University, Atlanta, GA, USA., Sims M; Section of Infectious Diseases and International Medicine, Department of Internal Medicine, Beaumont Royal Oak, Royal Oak, MI, USA.; Departments of Internal Medicine and Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI, USA., Silverman M; Western University, London, ON, Canada., Louie TJ; Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Feuerstadt P; Division of Digestive Disease, Yale University School of Medicine, New Haven, CT, USA.; PACT-Gastroenterology Center, Hamden, CT, USA., Huang ES; Department of Gastroenterology, Palo Alto Medical Foundation, Sutter Health, Mountain View, CA, USA., Khanna S; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA., Berenson CS; University at Buffalo, VA Western New York Healthcare System, Buffalo, NY, USA., Wang EEL; Seres Therapeutics, 200 Sidney Street, Cambridge, MA, 02139, USA., Cohen SH; University of California Davis Health, Sacramento, CA, USA., Korman L; Gastroenterology and Hepatology, Chevy Chase Clinical Research, Chevy Chase, MD, USA., Lee C; Island Medical Program, University of British Columbia and University of Victoria, Vancouver, BC, Canada., Kelly CR; Division of Gastroenterology, Brigham and Women's Hospital, Boston, MA, USA., Odio A; Adventist Health, Simi Valley, CA, USA., Cook PP; Brody School of Medicine at East, Carolina University, Greenville, NC, USA., Lashner B; Cleveland Clinic, Cleveland, OH, USA., Ramesh M; Division of Infectious Diseases, Henry Ford Health, Detroit, MI, USA., Kumar P; Division of Infectious Diseases and Tropical Medicine, Georgetown University Medical Center, Washington, DC, USA., De A; Seres Therapeutics, 200 Sidney Street, Cambridge, MA, 02139, USA., Memisoglu A; Seres Therapeutics, 200 Sidney Street, Cambridge, MA, 02139, USA., Lombardi DA; Seres Therapeutics, 200 Sidney Street, Cambridge, MA, 02139, USA., Hasson BR; Seres Therapeutics, 200 Sidney Street, Cambridge, MA, 02139, USA. bhasson@serestherapeutics.com., McGovern BH; Seres Therapeutics, 200 Sidney Street, Cambridge, MA, 02139, USA., von Moltke L; Seres Therapeutics, 200 Sidney Street, Cambridge, MA, 02139, USA., Pardi DS; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Corporate Authors: ECOSPOR III and ECOSPOR IV investigators
Source: Infectious diseases and therapy [Infect Dis Ther] 2024 Oct; Vol. 13 (10), pp. 2105-2121. Date of Electronic Publication: 2024 Jun 28.
Publication Type: Journal Article
Journal Info: Publisher: Adis Country of Publication: New Zealand NLM ID: 101634499 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8229 (Print) Linking ISSN: 21936382 NLM ISO Abbreviation: Infect Dis Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38941068
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kraft+CS%22">Kraft CS</searchLink>; Department of Pathology and Laboratory Medicine, Division of Infectious Diseases, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Sims+M%22">Sims M</searchLink>; Section of Infectious Diseases and International Medicine, Department of Internal Medicine, Beaumont Royal Oak, Royal Oak, MI, USA.; Departments of Internal Medicine and Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI, USA.<br /><searchLink fieldCode="AU" term="%22Silverman+M%22">Silverman M</searchLink>; Western University, London, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Louie+TJ%22">Louie TJ</searchLink>; Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Feuerstadt+P%22">Feuerstadt P</searchLink>; Division of Digestive Disease, Yale University School of Medicine, New Haven, CT, USA.; PACT-Gastroenterology Center, Hamden, CT, USA.<br /><searchLink fieldCode="AU" term="%22Huang+ES%22">Huang ES</searchLink>; Department of Gastroenterology, Palo Alto Medical Foundation, Sutter Health, Mountain View, CA, USA.<br /><searchLink fieldCode="AU" term="%22Khanna+S%22">Khanna S</searchLink>; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Berenson+CS%22">Berenson CS</searchLink>; University at Buffalo, VA Western New York Healthcare System, Buffalo, NY, USA.<br /><searchLink fieldCode="AU" term="%22Wang+EEL%22">Wang EEL</searchLink>; Seres Therapeutics, 200 Sidney Street, Cambridge, MA, 02139, USA.<br /><searchLink fieldCode="AU" term="%22Cohen+SH%22">Cohen SH</searchLink>; University of California Davis Health, Sacramento, CA, USA.<br /><searchLink fieldCode="AU" term="%22Korman+L%22">Korman L</searchLink>; Gastroenterology and Hepatology, Chevy Chase Clinical Research, Chevy Chase, MD, USA.<br /><searchLink fieldCode="AU" term="%22Lee+C%22">Lee C</searchLink>; Island Medical Program, University of British Columbia and University of Victoria, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Kelly+CR%22">Kelly CR</searchLink>; Division of Gastroenterology, Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Odio+A%22">Odio A</searchLink>; Adventist Health, Simi Valley, CA, USA.<br /><searchLink fieldCode="AU" term="%22Cook+PP%22">Cook PP</searchLink>; Brody School of Medicine at East, Carolina University, Greenville, NC, USA.<br /><searchLink fieldCode="AU" term="%22Lashner+B%22">Lashner B</searchLink>; Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Ramesh+M%22">Ramesh M</searchLink>; Division of Infectious Diseases, Henry Ford Health, Detroit, MI, USA.<br /><searchLink fieldCode="AU" term="%22Kumar+P%22">Kumar P</searchLink>; Division of Infectious Diseases and Tropical Medicine, Georgetown University Medical Center, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22De+A%22">De A</searchLink>; Seres Therapeutics, 200 Sidney Street, Cambridge, MA, 02139, USA.<br /><searchLink fieldCode="AU" term="%22Memisoglu+A%22">Memisoglu A</searchLink>; Seres Therapeutics, 200 Sidney Street, Cambridge, MA, 02139, USA.<br /><searchLink fieldCode="AU" term="%22Lombardi+DA%22">Lombardi DA</searchLink>; Seres Therapeutics, 200 Sidney Street, Cambridge, MA, 02139, USA.<br /><searchLink fieldCode="AU" term="%22Hasson+BR%22">Hasson BR</searchLink>; Seres Therapeutics, 200 Sidney Street, Cambridge, MA, 02139, USA. bhasson@serestherapeutics.com.<br /><searchLink fieldCode="AU" term="%22McGovern+BH%22">McGovern BH</searchLink>; Seres Therapeutics, 200 Sidney Street, Cambridge, MA, 02139, USA.<br /><searchLink fieldCode="AU" term="%22von+Moltke+L%22">von Moltke L</searchLink>; Seres Therapeutics, 200 Sidney Street, Cambridge, MA, 02139, USA.<br /><searchLink fieldCode="AU" term="%22Pardi+DS%22">Pardi DS</searchLink>; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22ECOSPOR III+and+ECOSPOR IV+investigators%22">ECOSPOR III and ECOSPOR IV investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101634499%22">Infectious diseases and therapy</searchLink> [Infect Dis Ther] 2024 Oct; Vol. 13 (10), pp. 2105-2121. <i>Date of Electronic Publication: </i>2024 Jun 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%22">Adis </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101634499 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2193-8229 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221936382%22">21936382 </searchLink><i>NLM ISO Abbreviation: </i>Infect Dis Ther <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38941068
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40121-024-01007-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2105
    Titles:
      – TitleFull: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kraft CS
      – PersonEntity:
          Name:
            NameFull: Sims M
      – PersonEntity:
          Name:
            NameFull: Silverman M
      – PersonEntity:
          Name:
            NameFull: Louie TJ
      – PersonEntity:
          Name:
            NameFull: Feuerstadt P
      – PersonEntity:
          Name:
            NameFull: Huang ES
      – PersonEntity:
          Name:
            NameFull: Khanna S
      – PersonEntity:
          Name:
            NameFull: Berenson CS
      – PersonEntity:
          Name:
            NameFull: Wang EEL
      – PersonEntity:
          Name:
            NameFull: Cohen SH
      – PersonEntity:
          Name:
            NameFull: Korman L
      – PersonEntity:
          Name:
            NameFull: Lee C
      – PersonEntity:
          Name:
            NameFull: Kelly CR
      – PersonEntity:
          Name:
            NameFull: Odio A
      – PersonEntity:
          Name:
            NameFull: Cook PP
      – PersonEntity:
          Name:
            NameFull: Lashner B
      – PersonEntity:
          Name:
            NameFull: Ramesh M
      – PersonEntity:
          Name:
            NameFull: Kumar P
      – PersonEntity:
          Name:
            NameFull: De A
      – PersonEntity:
          Name:
            NameFull: Memisoglu A
      – PersonEntity:
          Name:
            NameFull: Lombardi DA
      – PersonEntity:
          Name:
            NameFull: Hasson BR
      – PersonEntity:
          Name:
            NameFull: McGovern BH
      – PersonEntity:
          Name:
            NameFull: von Moltke L
      – PersonEntity:
          Name:
            NameFull: Pardi DS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2024 Oct
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2193-8229
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Infectious diseases and therapy
              Type: main
ResultId 1